Emergent BioSolutions to Present at Wedbush 2012 Life Sciences Management Access Conference
<0> Emergent BioSolutions Inc.Robert G. BurrowsVice President, Investor RelationsorTracey SchmittVice President, Corporate Communications </0>
Emergent BioSolutions Inc. (NYSE: EBS) announced today that the company will be webcasting its presentation at the Wedbush 2012 Life Sciences Management Access Conference in New York on Tuesday, August 14, 2012 at 8:00 AM Eastern. During the presentation, a member of the company’s management team will provide a corporate overview, which may include a discussion of the company’s recent business developments.
A webcast of this presentation will be available both live and by replay, accessible from the Emergent website under “Investors”.
Emergent BioSolutions protects and enhances life by developing and manufacturing vaccines and therapeutics that are supplied to healthcare providers and purchasers for use in preventing and treating disease. Emergent's marketed and investigational products target infectious diseases, oncology and autoimmune disorders. Additional information about the company may be found at . Follow us on twitter: @emergentbiosolu.